JOSEPH HARASZTI: Open Payments
NPI 1316087422 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 20 payments from 7 companies in 2025. Trend: 2023 $706 · 2024 $791 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, ARISTADA, TRINTELLIX, LYBALVI, Jornay PM, Auvelity, LOREEV XR, REXULTI.
Industry payments across CA — which companies pay providers there.
